Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation
dc.contributor.author | Rubio Langre, Sonia | |
dc.contributor.author | Aguilar Sola, Soledad | |
dc.contributor.author | Lorenzutti, Augusto Matías | |
dc.contributor.author | San Andrés Larrea, Manuel Ignacio | |
dc.contributor.author | Lucas Burneo, José Julio De | |
dc.contributor.author | Litterio, Nicolás J. | |
dc.date.accessioned | 2024-12-12T13:00:59Z | |
dc.date.available | 2024-12-12T13:00:59Z | |
dc.date.issued | 2018 | |
dc.description | JUSTIFICACIÓN DE AUTORES All authors have read and approved the final manuscript. S. R. L.: Design, acquisition, analysis and interpretation of data. S. A. S.: Acquisition, analysis and interpretation of data. A. M. L.: Analysis, interpretation of data and drafting the manuscript. M. I. S. A.: Design and critical revision of the manuscript for important intellectual content. J. J. D. L.: Acquisition, analysis of data and critical revision of the manuscript for important intellectual content. N. J. L.: Design and critical revision of the manuscript for important intellectual content. | |
dc.description.abstract | In llama crias (tekes), Escherichia coli and Staphylococcus aureus are major pathogens, and marbofloxacin could be a suitable choice. The objectives of this study were (a) to evaluate the serum pharmacokinetics of marbofloxacin (5 mg/kg) after intravenous administration in tekes and simulate a multidose regimen; (b) to emulate pharmacokinetic profiles after single dose and steady-state conditions by Monte Carlo simulation (c) to determine the MIC of regional strains of Escherichia coli and Staphylococcus aureus; (d) to perform a PK/PD analysis by Monte Carlo simulation. Pharmacokinetics of marbofloxacin was evaluated in six animals at 3, 10, 24, 50, and 80 days after birth. Marbofloxacin were determined by HPLC. A steady-state multi-dose simulation was carried out, and concentration-time profiles were generated by Monte Carlo simulation. MIC of marbofloxacin against regional E. coli and S. aureus strains were also determined. Finally, a PK/PD analysis was conducted by Monte Carlo simulation. After pharmacokinetic analysis, clearance showed a trend to increase (0.14 and 0.18 L kg−1 hr−1), and AUC (36.74 and 15.21 μg hr−1 ml−1) and Vss (3.06 and 3.37 L/kg) trended to decrease at 3 and 80 days-old, respectively, showing accumulation ~50% in animals with 3 days. All strains tested of E. coli (MIC90 = 0.06 μg/ml) and S. aureus (MIC90 = 0.25 μg/ml) were susceptible to marbofloxacin. PK/PD analysis suggests that the therapeutic regimen of marbofloxacin could be effective for infections caused by E. coli strains in animals between 3 and 80 days, with a CFR for Cmax/MIC > 10 of 100% and for AUC24/MIC > 125 of 99.99%; and for infections produced by S. aureus in animals between 3 and 24 days old, with a CFR for Cmax/MIC > 10 of 93.08% and for AUC24/MIC > 60 of 97.01%, but a higher dose should be used in older animals, because PK/PD endpoints were not met. | |
dc.description.department | Sección Deptal. de Farmacología y Toxicología (Veterinaria) | |
dc.description.faculty | Fac. de Veterinaria | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Universidad Complutense de Madrid | |
dc.description.sponsorship | Universidad Católica de Córdoba (Argentina) | |
dc.description.status | pub | |
dc.identifier.citation | Rubio-Langre S, Aguilar-Sola S, Lorenzutti AM, San Andrés MI, De Lucas JJ, Litterio NJ. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation. J vet Pharmacol Therap. 2018; 41: 861–870. https://doi.org/10.1111/jvp.12698 | |
dc.identifier.doi | 10.1111/jvp.12698 | |
dc.identifier.essn | 1365-2885 | |
dc.identifier.essn | 0140-7783 | |
dc.identifier.officialurl | https://doi.org/10.1111/JVP.12698 | |
dc.identifier.pmid | 30020535 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/112530 | |
dc.issue.number | 6 | |
dc.journal.title | Journal of Veterinary Pharmacology and Therapeutics | |
dc.language.iso | eng | |
dc.page.final | 870 | |
dc.page.initial | 861 | |
dc.publisher | Wiley | |
dc.rights.accessRights | restricted access | |
dc.subject.cdu | 636.09:615 | |
dc.subject.keyword | Llamas | |
dc.subject.keyword | Marbofloxacin | |
dc.subject.keyword | Monte Carlo simulation | |
dc.subject.keyword | Pharmacodynamics | |
dc.subject.keyword | Pharmacokinetics | |
dc.subject.ucm | Farmacología veterinaria | |
dc.subject.ucm | Ciencias Biomédicas | |
dc.subject.unesco | 3109.08 Farmacología | |
dc.title | Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 41 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | e7470fe4-3dc5-4906-9268-64fad1e71642 | |
relation.isAuthorOfPublication | cac20145-bbd1-4b94-9c81-0349adc65fa4 | |
relation.isAuthorOfPublication | 8da3734c-6aae-4b8d-b6d7-a32bc113d18a | |
relation.isAuthorOfPublication.latestForDiscovery | e7470fe4-3dc5-4906-9268-64fad1e71642 |
Download
Original bundle
1 - 1 of 1